dc.creatorLAKSHMI,K.S
dc.creatorRAJESH,T
dc.date2010-06-01
dc.date.accessioned2017-03-07T16:26:02Z
dc.date.available2017-03-07T16:26:02Z
dc.identifierhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072010000200023
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/401544
dc.descriptionA simple reverse phase high performance liquid chromatographic method was developed for the simultaneous determination of rosiglitazone (RGL) and gliclazide (GLC) in puré and pharmaceutical dosage forms. Aphenomenex Gemini reverse phase C column (150x4.6mm i.d., 5µ) was used with a mobile phase containing a mixture of acetonitrile and water (pH 3 adjusted with ortho phosphoric acid) in the ratio of 70: 30. The flow rate was 0.6mL/min. and effluents were monitored at 250nm and eluted at 2.41min. (RGL) and 5.22min. (GLC). Calibration curve was plotted with a range from 0.025-2.5µg/mL for RGL and 0.08 to 8µg/mL for GLC. The assay was validated for the parameters like accuracy (>97.87% recovery), precision (intra-day and inter-day with %RSD < 2), robustness and system suitability parameters. Henee the method was found to suitable for the routine quality control of the drugs in puré and pharmaceutical dosage forms.
dc.formattext/html
dc.languageen
dc.publisherSociedad Chilena de Química
dc.sourceJournal of the Chilean Chemical Society v.55 n.2 2010
dc.subjectRosiglitazone
dc.subjectGliclazide
dc.subjectRP-HPLC
dc.subjectvalidation
dc.subjectPharmaceutical dosage forms
dc.titleSIMULTANEOUS DETERMINATION OF ROSIGLITAZONE AND GLICLAZIDE IN PHARMACEUTICAL DOSAGE FORMS BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución